Bill Text: NY A04571 | 2019-2020 | General Assembly | Introduced

Bill Title: Requires the brand name of a prescribed drug to be indicated on the label when substitute drug products are dispensed.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced) 2019-02-04 - referred to consumer affairs and protection [A04571 Detail]

Download: New_York-2019-A04571-Introduced.html

                STATE OF NEW YORK
                               2019-2020 Regular Sessions
                   IN ASSEMBLY
                                    February 4, 2019
        Introduced  by M. of A. SMULLEN -- read once and referred to the Commit-
          tee on Consumer Affairs and Protection
        AN ACT to amend the education law, in relation to  certain  requirements
          when substitute drug products are dispensed
          The  People of the State of New York, represented in Senate and Assem-
        bly, do enact as follows:
     1    Section 1. Paragraph (c) of subdivision 1 of  section  6816-a  of  the
     2  education  law,  as added by chapter 776 of the laws of 1977, is amended
     3  to read as follows:
     4    (c) The pharmacist shall indicate on the label affixed to the  immedi-
     5  ate  container  in  which  the  drug  is  sold or dispensed the name and
     6  strength of the drug product and its manufacturer unless the  prescriber
     7  specifically states otherwise, and shall also indicate the brand name of
     8  the  drug  prescribed.  The  pharmacist shall record on the prescription
     9  form the brand name or the name of the manufacturer of the drug  product
    10  dispensed.
    11    §  2.  This  act shall take effect on the thirtieth day after it shall
    12  have become a law.
         EXPLANATION--Matter in italics (underscored) is new; matter in brackets
                              [ ] is old law to be omitted.